Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-l-tyrosine PET
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-l-tyrosine PET
Authors
Keywords
Pseudoprogression, Tumour progression, Glioblastoma, FET PET
Journal
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Volume 42, Issue 5, Pages 685-695
Publisher
Springer Nature
Online
2014-11-21
DOI
10.1007/s00259-014-2959-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Differentiation of Tumor Progression from Pseudoprogression in Patients with Posttreatment Glioblastoma Using Multiparametric Histogram Analysis
- (2014) J. Cha et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Dynamic 18F-FET PET in Newly Diagnosed Astrocytic Low-Grade Glioma Identifies High-Risk Patients
- (2013) N. L. Jansen et al. JOURNAL OF NUCLEAR MEDICINE
- Role of O-(2-18F-Fluoroethyl)-L-Tyrosine PET as a Diagnostic Tool for Detection of Malignant Progression in Patients with Low-Grade Glioma
- (2013) N. Galldiks et al. JOURNAL OF NUCLEAR MEDICINE
- Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-l-tyrosine PET in comparison to MRI
- (2012) Norbert Galldiks et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Late and Prolonged Pseudoprogression in Glioblastoma After Treatment With Lomustine and Temozolomide
- (2012) Moritz Stuplich et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessment of Treatment Response in Patients with Glioblastoma Using O-(2-18F-Fluoroethyl)-L-Tyrosine PET in Comparison to MRI
- (2012) N. Galldiks et al. JOURNAL OF NUCLEAR MEDICINE
- Diagnostic Performance of 18F-FET PET in Newly Diagnosed Cerebral Lesions Suggestive of Glioma
- (2012) M. Rapp et al. JOURNAL OF NUCLEAR MEDICINE
- Role of O-(2-18F-Fluoroethyl)-L-Tyrosine PET for Differentiation of Local Recurrent Brain Metastasis from Radiation Necrosis
- (2012) N. Galldiks et al. JOURNAL OF NUCLEAR MEDICINE
- Performance of 18F-Fluoro-Ethyl-Tyrosine (18F-FET) PET for the Differential Diagnosis of Primary Brain Tumor: A Systematic Review and Metaanalysis
- (2012) V. Dunet et al. JOURNAL OF NUCLEAR MEDICINE
- Percent Change of Perfusion Skewness and Kurtosis: A Potential Imaging Biomarker for Early Treatment Response in Patients with Newly Diagnosed Glioblastomas
- (2012) Hye Jin Baek et al. RADIOLOGY
- Brain Tumors
- (2012) Karl Herholz et al. SEMINARS IN NUCLEAR MEDICINE
- Diagnostic Dilemma of Pseudoprogression in the Treatment of Newly Diagnosed Glioblastomas: The Role of Assessing Relative Cerebral Blood Flow Volume and Oxygen-6-Methylguanine-DNA Methyltransferase Promoter Methylation Status
- (2011) D.-S. Kong et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Pseudoprogression and Pseudoresponse: Imaging Challenges in the Assessment of Posttreatment Glioma
- (2011) L.C. Hygino da Cruz et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine (F-18 FET) PET for Glioma Grading
- (2011) Maria Lucia Calcagni et al. CLINICAL NUCLEAR MEDICINE
- O-(2-18F-Fluoroethyl)-L-Tyrosine PET Predicts Failure of Antiangiogenic Treatment in Patients with Recurrent High-Grade Glioma
- (2011) M. Hutterer et al. JOURNAL OF NUCLEAR MEDICINE
- Potential utility of conventional MRI signs in diagnosing pseudoprogression in glioblastoma
- (2011) R. J. Young et al. NEUROLOGY
- German guidelines for brain tumour imaging by PET and SPECT using labelled amino acids
- (2011) K.-J. Langen et al. NUKLEARMEDIZIN-NUCLEAR MEDICINE
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
- (2010) Patrick Y. Wen et al. JOURNAL OF CLINICAL ONCOLOGY
- Changes in Relative Cerebral Blood Volume 1 Month after Radiation-Temozolomide Therapy Can Help Predict Overall Survival in Patients with Glioblastoma
- (2010) Rajiv Mangla et al. RADIOLOGY
- Posttreatment High-Grade Glioma: Usefulness of Peak Height Position with Semiquantitative MR Perfusion Histogram Analysis in an Entire Contrast-enhanced Lesion for Predicting Volume Fraction of Recurrence
- (2010) Ho Sung Kim et al. RADIOLOGY
- Prognostic Significance of Molecular Markers and Extent of Resection in Primary Glioblastoma Patients
- (2009) J. Felsberg et al. CLINICAL CANCER RESEARCH
- Pseudoprogression and pseudoresponse in the treatment of gliomas
- (2009) Dieta Brandsma et al. CURRENT OPINION IN NEUROLOGY
- New advances that enable identification of glioblastoma recurrence
- (2009) Isaac Yang et al. Nature Reviews Clinical Oncology
- Distinguishing Glioma Recurrence from Treatment Effect After Radiochemotherapy and Immunotherapy
- (2009) Isaac Yang et al. NEUROSURGERY CLINICS OF NORTH AMERICA
- Pathological review of late cerebral radionecrosis
- (2008) Yoshihiko Yoshii Brain Tumor Pathology
- MGMTPromoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomitant Radiochemotherapy in Newly Diagnosed Glioblastoma Patients
- (2008) Alba A. Brandes et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas
- (2008) Dieta Brandsma et al. LANCET ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation